APA Alıntı

Gris-Oliver, A., Ibrahim, Y. H., Rivas, M. A., García-García, C., Sánchez-Guixé, M., Ruiz-Pace, F., . . . Serra, V. (2021). PI3K activation promotes resistance to eribulin in HER2-negative breast cancer. Br J Cancer.

Chicago Stili Alıntı

Gris-Oliver, Albert, et al. "PI3K Activation Promotes Resistance to Eribulin in HER2-negative Breast Cancer." Br J Cancer 2021.

MLA Alıntı

Gris-Oliver, Albert, et al. "PI3K Activation Promotes Resistance to Eribulin in HER2-negative Breast Cancer." Br J Cancer 2021.